Research programme: hypersensitivity LAMP vaccines - Immunomic TherapeuticsAlternative Names: Multi allergen vaccine - Immunomic; MULTI-LAMP-vax
Latest Information Update: 07 Mar 2017
At a glance
- Originator Immunomic Therapeutics
- Developer Astellas Pharma; Immunomic Therapeutics
- Class DNA vaccines; Food allergy immunotherapies
- Mechanism of Action Th1 cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Hypersensitivity